ADA Scientific Sessions 2026 Abstract·6 JunMedical Spending Before and After GLP-1RA Initiation among Commercially Insured Adults Aged 18–64 Years with Type 2 DiabetesStudy in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·6 JunSocioeconomic Differences in Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors among Eligible U.S. Adults with Type 2 DiabetesStudy in peoplePopulationsPaper
ADA Scientific Sessions 2026 Abstract·6 JunImpact of GLP-1RA Initiation on Medical Expenditures in Medicare Beneficiaries with Type 2 DiabetesStudy in peopleInterventionsPaper